New Study on Research Reproducibility Proposes Fixes for $28 Billion Problem
Global Biological Standards Institute (GBSI)Approximately $28 billion per year is spent on preclinical research that is not reproducible AND the cumulative prevalence of irreproducible preclinical research exceeds 50 percent. The study, The Economics of Reproducibility in Preclinical Research, by Drs. Leonard P. Freedman, Iain M. Cockburn and Timothy S. Simcoe, outlines a framework for solutions and a plan for long-term improvements in life science research reproducibility rates.